share_log

Piper Sandler Maintains Overweight on Q32 Bio, Lowers Price Target to $20

Benzinga ·  Dec 11 21:09  · Ratings

Piper Sandler analyst Christopher Raymond maintains Q32 Bio (NASDAQ:QTTB) with a Overweight and lowers the price target from $85 to $20.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment